RNA immunization coupled with single-cell screening overcomes key limitations of classical immunization, enabling rapid generation of diverse antibodies against challenging membrane targets.
🧪 Heading to #AACR2025 and interested…
Mimabs will be at AACR Annual…
Festival of Biologics USA 2025 Meet…
4th Novel Conjugates Summit 2025 Meet…
11th Immuno-Oncology 360° Summit 2025 Nathalie…
Meet us at BIO-EUROPE SPRING 2025…
We are at the 15th World…
Mimabs at the ASH 2024 MImAbs…
Register to our Beacon® Webinar : mRNA…
Mimabs attending the SITC 2024 MImAbs…
Connect with MImAbs at the Nordic…
Connect with MImAbs at the 9th…
MImAbs will be attending at the…
Contact MimAbs to discuss your project, our team will support you in the scientific study and strategic development planning of your project.
Contact an expertBy managing risks early and throughout preclinical stages.
By selecting the best candidates
early based on function.
By offering an integrated development with proven results.
By sharing know-how, we guide your antibody projects.
By customizing approaches and technologies, we fit your unique needs.